Search research articles
Contact Us
Filters
Showing results (141-150 of 222) with videos related to
Page
of 23
Sort By:
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
The Lancet. HIV
|
April 3, 2016
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
Joel E Gallant, Eric S Daar, François Raffi, et al.
AIDS (London, England)
|
April 25, 2022
High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I
Paul E Sax, Kristen Andreatta, Jean-Michel Molina, et al.
The New England Journal of Medicine
|
August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIV
Susan J Little, Sarah Holte, Jean-Pierre Routy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2019
Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data
Ank E Nijhawan, Lisa R Metsch, Song Zhang, et al.
Scientific Reports
|
August 25, 2015
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy
Marta Massanella, Sara Gianella, Rachel Schrier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2020
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation
Trevor A Crowell, Justin Ritz, Robert W Coombs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 6, 2007
A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients
Brookie M Best, Miguel Goicoechea, Mallory D Witt, et al.
Journal of Virology
|
February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection
Andrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 222) with videos related to
Sort By:
Page
of 23
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
The Lancet. HIV
|
April 3, 2016
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
Joel E Gallant, Eric S Daar, François Raffi, et al.
AIDS (London, England)
|
April 25, 2022
High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I
Paul E Sax, Kristen Andreatta, Jean-Michel Molina, et al.
The New England Journal of Medicine
|
August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIV
Susan J Little, Sarah Holte, Jean-Pierre Routy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2019
Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data
Ank E Nijhawan, Lisa R Metsch, Song Zhang, et al.
Scientific Reports
|
August 25, 2015
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy
Marta Massanella, Sara Gianella, Rachel Schrier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 31, 2020
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation
Trevor A Crowell, Justin Ritz, Robert W Coombs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 6, 2007
A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients
Brookie M Best, Miguel Goicoechea, Mallory D Witt, et al.
Journal of Virology
|
February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection
Andrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.
Page
of 23